Skip to main content
. 2016 Oct;59(5):322–329. doi: 10.1503/cjs.004016

Table 1.

Demographic and clinical characteristics of the included patients based on transfusion status

Characteristic Group; no. (%) or mean (IQR) p value
Transfused (n = 535) Nontransfused (n = 2349)
Age, yr < 0.001
 < 40 10 (1.9) 77 (3.3)
 40–64 142 (26.5) 862 (36.7)
 65–74 168 (31.4) 683 (29.0)
 ≥ 75 215 (40.2) 727 (31.0)
Male sex 320 (59.8) 1366 (58.1) 0.48
Race 0.05
 White 255 (47.7) 1132 (48.2)
 Black 83 (15.5) 323 (13.8)
 Other 46 (8.6) 293 (12.5)
 Unknown 151 (28.2) 601 (25.6)
ASA Score < 0.001
 I 3 (0.56) 30 (1.3)
 II 99 (18.5) 761 (32.4)
 III 363 (67.9) 1434 (61.1)
 IV/V 70 (13.1) 124 (5.3)
BMI 0.13
 < 20 56 (10.5) 203 (8.6)
 20–29 352 (65.8) 1576 (67.0)
 30–40 99 (18.5) 476 (20.3)
 ≥ 40 23 (4.3) 62 (2.6)
 Unknown 5 (0.93) 32 (1.4)
Diabetes 134 (22.8) 453 (19.3) 0.003
Active smoker 80 (15.7) 431 (18.4) 0.06
COPD 47 (8.8) 113 (4.8) < 0.001
Dyspnea < 0.001
 At rest 13 (2.4) 12 (0.51)
 With moderate exertion 91 (17.0) 235 (10.0)
Hypertension 353 (66.0) 1417 (60.3) 0.015
Cardiac comorbidity 535 (67.1) 1422 (60.6) 0.005
Bleeding disorder 38 (7.1) 74 (3.2) < 0.001
Corticosteroid use 11 (2.1) 40 (1.7) 0.58
Weight loss > 10% 112 (20.9) 326 (13.9) < 0.001
Preoperative albumin < 3g/dL 358 (66.9) 1710 (72.8) < 0.001
Preoperative serum albumin (g/dL) 3.4 (3.0–3.9) 3.8 (3.5–4.2) < 0.001
Preoperative hematocrit (%) 31.7 (28.4–37.7) 36.9 (33.7–40.4) < 0.001
Preoperative INR 1.1 (1.0–4.4) 1.0 (1.0–3.6) < 0.001
Preoperative chemotherapy (within 30 d of surgery) 29 (5.4) 159 (6.8) 0.47
Preoperative radiation therapy (within 30 d of surgery) 10 (1.9) 54 (2.3) 0.79

ASA = American Society of Anesthesiologists; BMI = body mass index; COPD = chronic pulmonary obstructive disease; INR = international normalized ratio; IQR = interquartile range.